Exane Derivatives’s Jacobs Solutions J Stock Holding History
Bought
Maintained
Sold
Other funds holding J
RCG
Exane Derivatives's J Position: Q2 2022 in Review
Exane Derivatives reduced its Jacobs Solutions (J) stake by 17% in Q2 2022, selling an estimated $83.9K and leaving 3,581 shares worth $377K. The position accounts for 0.22% of the portfolio, ranked #115.
Exane Derivatives first reported a position in J in Q3 2015 and has held it in 23 quarters since. The position peaked at $1.15M in Q4 2017. 692 funds tracked by Wall St. Rank hold J as of Q2 2022.
- Exane Derivatives held 3,581 shares of Jacobs Solutions worth $377K as of Q2 2022.
- Exane Derivatives sold 750 Jacobs Solutions shares in Q2 2022, an estimated $83.9K.
- Jacobs Solutions made up 0.22% of Exane Derivatives's portfolio in Q2 2022, its #115 holding.
- Exane Derivatives first reported a position in Jacobs Solutions in Q3 2015 and has held it in 23 quarters since.
- Exane Derivatives's Jacobs Solutions position peaked at $1.15M in Q4 2017.
- 692 funds tracked by Wall St. Rank held Jacobs Solutions as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.